Patent Assignment
Reel/Frame 047450/0652
Certificate of Conversion
Recorded: 2018-08-09
Pages: 5
Assignor
TRIUS THERAPEUTICS, INC.
Executed: 2015-06-11
Assignee
TRIUS THERAPEUTICS LLC
2000 GALLOPING HILL ROAD, KENILWORTH, NEW JERSEY, 07033
Covered Properties
(3)
Forms of R)-3-(4-(2-(2-Methyltetrazol-5-Yl)Pyridin-5-Yl)-3-Fluorophenyl)-5-Hydroxymethyl Oxazolidin-2-One Dihydrogen Phosphate
Forms of R)-3-(4-(2-(2-Methyltetrazol-5-Yl)Pyridin-5-Yl)-3-Fluorophenyl)-5-Hydroxymethyl Oxazolidin-2-One Dihydrogen Phosphate
Forms of R)-3-(4-(2-(2-Methyltetrazol-5-Yl)Pyridin-5-Yl)-3-Fluorophenyl)-5-Hydroxymethyl Oxazolidin-2-One Dihydrogen Phosphate
Related Assignments
(3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Aug 9, 2018
From: REICHENBACHER, KATHARINA; DUGUID, ROBERT J.; PHILLIPSON, DOUGLAS; SIMSON, JACQUELINE A.
To: TRIUS THERAPEUTICS
Reel/Frame 046599/0838 →
Nunc Pro Tunc Assignment
Aug 9, 2018
From: TRIUS THERAPEUTICS LLC
To: MERCK SHARP & DOHME CORP.
Reel/Frame 046599/0987 →
Merger
Aug 8, 2022
From: MERCK SHARP & DOHME CORP.
To: MERCK SHARP & DOHME LLC
Reel/Frame 061102/0145 →